ACEIs and ARBs may reduce incidence of atrial fibrillation by their anti-inflammatory characteristics

Med Hypotheses. 2006;66(2):437. doi: 10.1016/j.mehy.2005.09.011. Epub 2005 Oct 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Angiotensin Receptor Antagonists*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Anti-Inflammatory Agents / therapeutic use*
  • Atrial Fibrillation / metabolism
  • Atrial Fibrillation / prevention & control*
  • C-Reactive Protein / metabolism
  • Humans

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Anti-Inflammatory Agents
  • C-Reactive Protein